4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001664281-26-000002
Director sold 116,474 shares at an average $6.93 ($807,027)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PARMAR KUSH Director | 2026-07-30 | Sale | −114,756 | $6.93 | $795,259 | 2,848,310 | I |
| PARMAR KUSH Director | 2026-07-31 | Sale | −1,718 | $6.85 | $11,768 | 2,846,592 | I |
| Open-market sales · 116,474 sh · avg $6.93 · $807,027 | |||||||
Loading xslF345X06/form4-08032026_090837.xml…